Showing codes Q5148 (Injection, filgrastim-txid (nypozi), biosimilar, 1 microgram) — Q9961 (High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml)

Q5148 - Inj, nyposi 1 mcg
Long description: Injection, filgrastim-txid (nypozi), biosimilar, 1 microgram
Code added date: 20250401.
Code effective date: 20250401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q5149 - Inj, aflibercept-abzv, 1 mg
Long description: Injection, aflibercept-abzv (enzeevu), biosimilar, 1 mg
Code added date: 20250401.
Code effective date: 20250401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5150 - Inj, aflibercept-mrbb, 1 mg
Long description: Injection, aflibercept-mrbb (ahzantive), biosimilar, 1 mg
Code added date: 20250401.
Code effective date: 20250401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5151 - Inj, eculizumab-aagh, 2 mg
Long description: Injection, eculizumab-aagh (epysqli), biosimilar, 2 mg
Code added date: 20250401.
Code effective date: 20250401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5152 - Inj, eculizumab-aeeb, 2 mg
Long description: Injection, eculizumab-aeeb (bkemv), biosimilar, 2 mg
Code added date: 20250401.
Code effective date: 20250701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5153 - Inj, aflibercept-yszy, 1 mg
Long description: Injection, aflibercept-yszy (opuviz), biosimilar, 1 mg
Code added date: 20250701.
Code effective date: 20250701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5154 - Inj, omlyclo, 5 mg
Long description: Injection, omalizumab-igec (omlyclo), biosimilar, 5 mg
Code added date: 20251001.
Code effective date: 20251001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5155 - Inj, aflibercept-jbvf, 1 mg
Long description: Injection, aflibercept-jbvf (yesafili), biosimilar, 1 mg
Code added date: 20251001.
Code effective date: 20251001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5156 - Inj, tocilizumab-anoh, 1 mg
Long description: Injection, tocilizumab-anoh (avtozma), biosimilar, 1 mg
Code added date: 20251001.
Code effective date: 20251001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5157 - Inj, denosumab-bmwo, 1 mg
Long description: Injection, denosumab-bmwo (stoboclo/osenvelt), biosimilar, 1 mg
Code added date: 20251001.
Code effective date: 20251001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5158 - Inj, denosumab-bnht, 1 mg
Long description: Injection, denosumab-bnht (bomyntra/conexxence), biosimilar, 1 mg
Code added date: 20251001.
Code effective date: 20251001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5159 - Inj, denosumab-dssb, 1 mg
Long description: Injection, denosumab-dssb (ospomyv/xbryk), biosimilar, 1 mg
Code added date: 20251001.
Code effective date: 20251001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q6 - Fee/time comp subst md or pt
Long description: Service furnished under a fee-for-time compensation arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area
Code added date: 19930101.
Code effective date: 20170701.
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q7 - One class a finding
Long description: One class a finding
Code added date: 19950101.
Code effective date: 19970101.
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q8 - Two class b findings
Long description: Two class b findings
Code added date: 19950101.
Code effective date: 19970101.
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q9 - 1 class b & 2 class c fndngs
Long description: One class b and two class c findings
Code added date: 19950101.
Code effective date: 19970101.
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q9001 - Chaplain assessment
Long description: Assessment by chaplain services
Code added date: 20201001.
Code effective date: 20221001.
Pricing Indicator Code(s): 99 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q9002 - Chaplain counsel individu
Long description: Counseling, individual, by chaplain services
Code added date: 20201001.
Code effective date: 20221001.
Pricing Indicator Code(s): 99 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q9003 - Chaplain counsel group
Long description: Counseling, group, by chaplain services
Code added date: 20201001.
Code effective date: 20221001.
Pricing Indicator Code(s): 99 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q9004 - Va whole health partner serv
Long description: Department of veterans affairs whole health partner services
Code added date: 20211001.
Code effective date: 20211001.
Pricing Indicator Code(s): 99 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q9950 - Inj sulf hexa lipid microsph
Long description: Injection, sulfur hexafluoride lipid microspheres, per ml
Code added date: 20160101.
Code effective date: 20240101.
Pricing Indicator Code(s): 57 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q9951 - Locm >= 400 mg/ml iodine,1ml
Long description: Low osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml
Code added date: 20050401.
Code effective date: 20050401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q9953 - Inj fe-based mr contrast,1ml
Long description: Injection, iron-based magnetic resonance contrast agent, per ml
Code added date: 20050401.
Code effective date: 20050401.
Pricing Indicator Code(s): 57 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q9954 - Oral mr contrast, 100 ml
Long description: Oral magnetic resonance contrast agent, per 100 ml
Code added date: 20050401.
Code effective date: 20050401.
Pricing Indicator Code(s): 57 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q9955 - Inj perflexane lip micros,ml
Long description: Injection, perflexane lipid microspheres, per ml
Code added date: 20050401.
Code effective date: 20050401.
Pricing Indicator Code(s): 57 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q9956 - Inj octafluoropropane mic,ml
Long description: Injection, octafluoropropane microspheres, per ml
Code added date: 20050401.
Code effective date: 20050401.
Pricing Indicator Code(s): 57 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q9957 - Inj perflutren lip micros,ml
Long description: Injection, perflutren lipid microspheres, per ml
Code added date: 20050401.
Code effective date: 20050401.
Pricing Indicator Code(s): 57 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q9958 - Hocm <=149 mg/ml iodine, 1ml
Long description: High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml
Code added date: 20050701.
Code effective date: 20050701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q9959 - Hocm 150-199mg/ml iodine,1ml
Long description: High osmolar contrast material, 150-199 mg/ml iodine concentration, per ml
Code added date: 20050701.
Code effective date: 20050701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q9960 - Hocm 200-249mg/ml iodine,1ml
Long description: High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml
Code added date: 20050701.
Code effective date: 20050701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q9961 - Hocm 250-299mg/ml iodine,1ml
Long description: High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml
Code added date: 20050701.
Code effective date: 20050701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF